These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35532800)

  • 1. [Conservative treatment of peripheral arterial disease].
    Espinola-Klein C; Weißer G
    Inn Med (Heidelb); 2022 Jun; 63(6):579-583. PubMed ID: 35532800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles of angiology in lower extremity arterial disease (LEAD)].
    Espinola-Klein C
    Herz; 2020 Apr; 45(2):201-208. PubMed ID: 32140731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we have a unified consensus on antithrombotic management of PAD?
    Poredos P; Antignani PL; Blinc A; Fras Z; Jezovnik MK; Fareed J; Mansilha A
    Int Angiol; 2021 Jun; 40(3):229-239. PubMed ID: 33739074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents for intermittent claudication.
    Wong PF; Chong LY; Mikhailidis DP; Robless P; Stansby G
    Cochrane Database Syst Rev; 2011 Nov; (11):CD001272. PubMed ID: 22071801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.
    Kaplovitch E; Eikelboom JW; Dyal L; Aboyans V; Abola MT; Verhamme P; Avezum A; Fox KAA; Berkowitz SD; Bangdiwala SI; Yusuf S; Anand SS
    JAMA Cardiol; 2021 Jan; 6(1):21-29. PubMed ID: 32997098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL; Fitridge R; Dawson J; Nicholls SJ
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in peripheral arterial disease.
    Espinola-Klein C; Weißer G; Schmitt V; Schwaderlapp M; Munzel T
    Front Cardiovasc Med; 2022; 9():927645. PubMed ID: 36312276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of peripheral arterial disease and intermittent claudication.
    Schainfeld RM
    J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in peripheral artery disease.
    Foley TR; Waldo SW; Armstrong EJ
    Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
    Di Minno G; Spadarella G; Cafaro G; Petitto M; Lupoli R; Di Minno A; de Gaetano G; Tremoli E
    Ann Med; 2014 Nov; 46(7):475-89. PubMed ID: 25045928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease.
    Armstrong EJ; Anderson DR; Yeo KK; Singh GD; Bang H; Amsterdam EA; Freischlag JA; Laird JR
    J Vasc Surg; 2015 Jul; 62(1):157-165.e1. PubMed ID: 25864042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary Medical Management of Peripheral Artery Disease.
    Bonaca MP; Hamburg NM; Creager MA
    Circ Res; 2021 Jun; 128(12):1868-1884. PubMed ID: 34110910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol for intermittent claudication.
    Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial.
    Ramacciotti E; Agati LB; Volpiani GG; Brito KF; Ribeiro CM; Aguiar VCR; Ramacciotti LS; Paganotti A; Pereira FM; Caffaro RA; Fioranelli A; Krakauer R; Rached HRS; Wolosker N; Anand SS; Eikelboom JW; Lopes RD
    Clin Appl Thromb Hemost; 2022; 28():10760296211073922. PubMed ID: 35043716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol for intermittent claudication.
    Brown T; Forster RB; Cleanthis M; Mikhailidis DP; Stansby G; Stewart M
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003748. PubMed ID: 34192807
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.